• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质谱细胞术分析显示,滤泡性淋巴瘤肿瘤内特定的 CD4+T 细胞亚群与患者生存相关。

Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma.

机构信息

Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Cell Rep. 2019 Feb 19;26(8):2178-2193.e3. doi: 10.1016/j.celrep.2019.01.085.

DOI:10.1016/j.celrep.2019.01.085
PMID:30784598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402596/
Abstract

Follicular lymphoma (FL) is an indolent B cell malignancy characterized by an extensive but poorly functional T cell infiltrate in the tumor microenvironment. Using mass cytometry, we identified at least 12 subsets of intratumoral CD4 T cells, 3 of which were unique to FL biopsies versus control tissues. Of these subsets, the frequency of naive T cells correlated with improved patient survival. Although total PD-1 T cell numbers were not associated with patient outcome, specific PD-1 T cell subpopulations were associated with poor survival. Intratumoral T cells lacking CD27 and CD28 co-stimulatory receptor expression were enriched in FL and correlated with inferior patient outcomes. In vitro models revealed that CD70 lymphoma cells played an important role in expanding this population. Taken together, our mass cytometry results identified CD4 memory T cell populations that are poorly functional due to loss of co-stimulatory receptor expression and are associated with an inferior survival in FL.

摘要

滤泡性淋巴瘤(FL)是一种惰性 B 细胞恶性肿瘤,其肿瘤微环境中存在广泛但功能较差的 T 细胞浸润。使用质谱流式细胞术,我们鉴定了至少 12 种肿瘤内 CD4 T 细胞亚群,其中 3 种仅存在于 FL 活检组织中,而不存在于对照组织中。在这些亚群中,幼稚 T 细胞的频率与患者生存改善相关。虽然总 PD-1 T 细胞数量与患者预后无关,但特定的 PD-1 T 细胞亚群与不良预后相关。缺乏 CD27 和 CD28 共刺激受体表达的肿瘤内 T 细胞在 FL 中富集,并与患者预后不良相关。体外模型表明,CD70 淋巴瘤细胞在扩增该细胞群中发挥了重要作用。综上所述,我们的质谱流式细胞术结果鉴定了由于共刺激受体表达缺失而功能较差的 CD4 记忆 T 细胞群体,与 FL 患者的不良生存相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/e1e9e5e7fa05/nihms-1522163-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/a1476c8c90e0/nihms-1522163-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/dd98cbfa3ccb/nihms-1522163-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/6677dc018e25/nihms-1522163-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/1431d11c0287/nihms-1522163-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/0a1a5817efa1/nihms-1522163-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/feb9d469da14/nihms-1522163-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/e1e9e5e7fa05/nihms-1522163-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/a1476c8c90e0/nihms-1522163-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/dd98cbfa3ccb/nihms-1522163-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/6677dc018e25/nihms-1522163-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/1431d11c0287/nihms-1522163-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/0a1a5817efa1/nihms-1522163-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/feb9d469da14/nihms-1522163-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2829/6402596/e1e9e5e7fa05/nihms-1522163-f0008.jpg

相似文献

1
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma.质谱细胞术分析显示,滤泡性淋巴瘤肿瘤内特定的 CD4+T 细胞亚群与患者生存相关。
Cell Rep. 2019 Feb 19;26(8):2178-2193.e3. doi: 10.1016/j.celrep.2019.01.085.
2
Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.CD27-CD70共刺激途径在同种异体T细胞对滤泡性淋巴瘤细胞反应中的作用。
Br J Haematol. 1999 Jul;106(1):64-70. doi: 10.1046/j.1365-2141.1999.01474.x.
3
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.程序性死亡受体1(PD-1)的表达定义了滤泡性淋巴瘤中两个不同的T细胞亚群,它们对患者生存的影响存在差异。
Blood Cancer J. 2015 Feb 20;5(2):e281. doi: 10.1038/bcj.2015.1.
4
TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti-PD-1 Response in Follicular Lymphoma.TIGIT 表达与 T 细胞抑制和耗竭相关,并可预测滤泡性淋巴瘤的临床结局和抗 PD-1 反应。
Clin Cancer Res. 2020 Oct 1;26(19):5217-5231. doi: 10.1158/1078-0432.CCR-20-0558. Epub 2020 Jul 6.
5
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.高 PD-1 表达和受抑制的细胞因子信号区分了浸润滤泡性淋巴瘤肿瘤的 T 细胞与外周 T 细胞。
Blood. 2013 Feb 21;121(8):1367-76. doi: 10.1182/blood-2012-04-421826. Epub 2013 Jan 7.
6
PD-1 analysis on CD28(-) CD27(-) CD4 T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients.PD-1 分析 CD28(-)CD27(-)CD4 T 细胞可在移植受者中独立于刺激评估 CMV 病毒血症发作。
Am J Transplant. 2013 Dec;13(12):3132-41. doi: 10.1111/ajt.12480. Epub 2013 Oct 22.
7
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.滤泡性淋巴瘤肿瘤内滤泡辅助 T 细胞的特征:恶性 B 细胞存活中的作用。
Leukemia. 2012 May;26(5):1053-63. doi: 10.1038/leu.2011.301. Epub 2011 Oct 21.
8
A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.滤泡性淋巴瘤的统一微环境模型:程序性死亡受体 1 阳性、调节性、细胞毒性、辅助性 T 细胞和巨噬细胞以及预后相关。
Clin Cancer Res. 2010 Jan 15;16(2):637-50. doi: 10.1158/1078-0432.CCR-09-2487. Epub 2010 Jan 12.
9
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.IL-12 上调 TIM-3 的表达并诱导滤泡性 B 细胞非霍奇金淋巴瘤患者 T 细胞耗竭。
J Clin Invest. 2012 Apr;122(4):1271-82. doi: 10.1172/JCI59806. Epub 2012 Mar 19.
10
Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.肿瘤微环境中滤泡程序性死亡 1 阳性淋巴细胞是滤泡淋巴瘤的独立预后因素。
Hum Pathol. 2011 Apr;42(4):552-7. doi: 10.1016/j.humpath.2010.08.015. Epub 2011 Jan 15.

引用本文的文献

1
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment.滤泡性淋巴瘤微环境中T细胞的深度免疫表型剖析及其临床影响
Haematologica. 2025 Aug 1;110(8):1808-1821. doi: 10.3324/haematol.2024.286383. Epub 2025 Feb 6.
2
A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies.一项针对低度B细胞淋巴瘤患者在原位治疗性癌症疫苗接种中添加OX40激动剂的I期临床试验凸显了从小鼠研究转化到人体研究的挑战。
Clin Cancer Res. 2025 Mar 3;31(5):868-880. doi: 10.1158/1078-0432.CCR-24-2770.
3

本文引用的文献

1
Expression of LAG-3 defines exhaustion of intratumoral PD-1 T cells and correlates with poor outcome in follicular lymphoma.LAG-3的表达定义了肿瘤内PD-1 T细胞的耗竭,并与滤泡性淋巴瘤的不良预后相关。
Oncotarget. 2017 May 29;8(37):61425-61439. doi: 10.18632/oncotarget.18251. eCollection 2017 Sep 22.
2
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.帕博利珠单抗用于慢性淋巴细胞白血病(CLL)合并Richter转化或复发CLL患者。
Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19.
3
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.
Follicular lymphoma research: an open dialogue for a collaborative roadmap.
滤泡性淋巴瘤研究:关于协作路线图的开放对话
Histopathology. 2025 Jan;86(1):79-93. doi: 10.1111/his.15344. Epub 2024 Oct 29.
4
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review.分子生物标志物在预测滤泡性淋巴瘤患者高级别转化和结局中的作用:一项全面的系统性综述。
Int J Mol Sci. 2024 Oct 17;25(20):11179. doi: 10.3390/ijms252011179.
5
High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma.高 Ki-67 表达预测滤泡性淋巴瘤 24 个月内疾病进展的风险因素和微环境。
Int J Mol Sci. 2024 Oct 15;25(20):11057. doi: 10.3390/ijms252011057.
6
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.淋巴瘤微小残留病灶检测:方法、程序及临床意义。
Front Immunol. 2024 Aug 12;15:1430070. doi: 10.3389/fimmu.2024.1430070. eCollection 2024.
7
Systemic and local immunosuppression in glioblastoma and its prognostic significance.脑胶质瘤的全身和局部免疫抑制及其预后意义。
Front Immunol. 2024 Feb 28;15:1326753. doi: 10.3389/fimmu.2024.1326753. eCollection 2024.
8
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.滤泡性淋巴瘤 B 细胞表现出具有相关体细胞改变和肿瘤微环境的异质性转录状态。
Cell Rep Med. 2024 Mar 19;5(3):101443. doi: 10.1016/j.xcrm.2024.101443. Epub 2024 Feb 29.
9
T-cell phenotype including CD57 T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.肿瘤微环境中的 T 细胞表型,包括 CD57 T 滤泡辅助细胞,与滤泡性淋巴瘤的不良预后相关。
Blood Cancer J. 2023 Aug 18;13(1):124. doi: 10.1038/s41408-023-00899-3.
10
Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.脾脏边缘区淋巴瘤肿瘤微环境中免疫衰竭和抑制的特征。
Leukemia. 2023 Jul;37(7):1485-1498. doi: 10.1038/s41375-023-01911-2. Epub 2023 Apr 28.
T细胞共刺激受体CD28是PD-1介导抑制作用的主要靶点。
Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9.
4
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.人类固有淋巴细胞亚群在表型和频率上具有基于组织类型的异质性。
Immunity. 2017 Jan 17;46(1):148-161. doi: 10.1016/j.immuni.2016.11.005. Epub 2016 Dec 13.
5
Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.滤泡性淋巴瘤肿瘤的质谱流式细胞术揭示了包括HLA-DR在内的蛋白质的内在异质性以及非恶性浆母细胞和生发中心B细胞群体的缺陷。
Cytometry B Clin Cytom. 2017 Jan;92(1):79-87. doi: 10.1002/cyto.b.21498.
6
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.早期事件状态可提示新诊断滤泡性淋巴瘤的后续预后。
Am J Hematol. 2016 Nov;91(11):1096-1101. doi: 10.1002/ajh.24492. Epub 2016 Sep 3.
7
CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis.狼疮性肾炎患者的CD3(+)CD8(+)CD28(-) T淋巴细胞
J Immunol Res. 2016;2016:1058165. doi: 10.1155/2016/1058165. Epub 2016 Jun 30.
8
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.纳武利尤单抗治疗复发或难治性血液系统恶性肿瘤患者:Ib期研究的初步结果
J Clin Oncol. 2016 Aug 10;34(23):2698-704. doi: 10.1200/JCO.2015.65.9789. Epub 2016 Jun 6.
9
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.程序性死亡受体1(PD-1)的表达定义了滤泡性淋巴瘤中两个不同的T细胞亚群,它们对患者生存的影响存在差异。
Blood Cancer J. 2015 Feb 20;5(2):e281. doi: 10.1038/bcj.2015.1.
10
TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.转化生长因子-β上调CD70表达并诱导B细胞非霍奇金淋巴瘤中效应性记忆T细胞耗竭。
Leukemia. 2014 Sep;28(9):1872-84. doi: 10.1038/leu.2014.84. Epub 2014 Feb 26.